TheiaNova has dosed the first patient in a proof-of-concept clinical study evaluating its investigational eye drop therapy for keratoconus.

A United States research team is studying how to restore vision in people who develop a form of inherited blindness, by delivering functional genetic

Eye growth and development in offspring of mothers with gestational diabetes mellitus (GDM) warrants closer attention, according to the authors of a population-based cross-sectional

GenEye 2026 – the disrupting force in ophthalmic education – returns to the Royal Victorian Eye and Ear Hospital from 20–22 May 2026, offering